The FDA approved enlicitide (Lipfendra; Merck), the first oral PCSK9 inhibitor for lowering low-density lipoprotein ...
A 12-week prospective cohort enrolled 73 patients with guideline-based asthma or COPD and no speech-affecting comorbidities, ...
Facility charges exceeded professional fees in variability for 25 of 26 services, with median facility interquartile ratios 2.56 versus 1.78 for professional prices ...
Propensity-matched comparisons across 11 Kaiser Permanente Southern California service areas showed similar 30-day composite ...
This study examines how key players in managed care drive postacute home health referrals, identifying tensions, limited ...
Deepak Bhatt, MD, MPH, MBA, discusses hot new topics reshaping care for diabetes, obesity, and cardiovascular disease. One example of this new era is the SURPASS-CVOT trial (NCT04255433), a ...
A rebate-driven formulary model allegedly incentivized higher insulin list prices, affecting three PBMs controlling roughly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results